Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

NeuroBo Pharmaceuticals, Inc. Common Stock (NRBO)

Pharmaceutical Preparations

https://www.neurobopharma.com

NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused primarily on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of nonalcoholic steatohepatitis (NASH), obesity, and type 2 diabetes (T2D): DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

545 CONCORD AVENUE, SUITE 210
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/04/2016

Market Cap

32,410,579

Shares Outstanding

4,850,000

Weighted SO

4,851,564

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

ALLR --.--%

HILS --.--%

VRAX --.--%

QNRX --.--%

KRBP --.--%

BDRX --.--%

ZURA --.--%

PHIO --.--%

SONN --.--%

Beta

-0.2910

Last Div

0.0000

Range

2.9-6.75

Chg

-0.0786

Avg Vol

62517

Mkt Cap

32410579

Exch

NASDAQ

Country

US

Phone

857 702 9600

DCF Diff

-0.4879

DCF

4.4029

Div Yield

0.0000

P/S

8102.6448

EV Multiple

-0.1753

P/FV

1.0981

Div Yield %

0.0000

P/E

-0.8031

PEG

-0.0092

Payout

0.0000

Current Ratio

2.9366

Quick Ratio

2.9366

Cash Ratio

2.8765

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

64045.3333

CCC

-64045.3333

Gross Margin

-2.7500

Op Margin

-6631.2500

Pretax Margin

-6474.7500

Net Margin

-6474.7500

Eff Tax Rate

0.0048

ROA

-0.9008

ROE

-1.5404

ROCE

-1.3931

NI/EBT

1.0000

EBT/EBIT

0.9764

EBIT/Rev

-6631.2500

Debt Ratio

0.0059

D/E

0.0090

LT Debt/Cap

0.0051

Total Debt/Cap

0.0089

Int Coverage

315.7738

CF/Debt

-117.0588

Equity Multi

1.5178

Rec Turnover

0.0000

Pay Turnover

0.0057

Inv Turnover

0.0000

FA Turnover

0.0188

Asset Turnover

0.0001

OCF/Share

-3.6656

FCF/Share

-3.6755

Cash/Share

5.1454

OCF/Sales

-4975.0000

FCF/OCF

1.0027

CF Coverage

-117.0588

ST Coverage

-276.3889

CapEx Coverage

-368.5185

Div&CapEx Cov

-368.5185

P/BV

1.0981

P/B

1.0981

P/S

8102.6448

P/E

-0.8031

P/FCF

-1.6243

P/OCF

-1.0452

P/CF

-1.0452

PEG

-0.0092

P/S

8102.6448

EV Multiple

-0.1753

P/FV

1.0981

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation